Tender Pharmacogenomic (PGx) Testing Service ulster university
Tender Pharmacogenomic (PGx) Testing Service ulster university
Reference: 6532577
Description
The project wishes to appoint a suitable laboratory or multiple labs to supply an end-to-end genomic testing service which provides genomic variant data for n=4,854 participants in Northern Ireland (NI) and Ireland. Specifically, the areas where the project will recruit participants from of relevance to this tender includes counties Londonderry, Tyrone in Northern Ireland and counties Donegal and Sligo in Ireland. The iMPROVE project will operate on the basis of a research implementation study which aims to integrate pharmacogenomic testing into a patient-centred medicines optimisation care pathway in GP practices across the project regions. The new integrated care pathway will be led by GP practice pharmacists with a focus on medicines optimisation to improve outcomes, removing inappropriate and ineffective treatments and adverse drug event risk reduction. Medications for pain, depression, anxiety and cardiovascular disease are the most prescribed drugs which also display considerable variation in efficacy, in part due to single nucleotide polymorphisms (SNPs) in genes which can alter efficient drug metabolism. A laboratory service is required to transport participant samples from GP sites, test for a finite list of SNPs which alter the rate of metabolism of a constrained list of prescribed medications including opioids, SSRI’s, PPI’s, statins and Clopidgrel.
Total value (estimated)
- £600,000 excluding VAT
- £720,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 3 August 2026 to 2 August 2028
- Possible extension to 3 August 2030
- 4 years, 1 day
Description of possible extension:
Any periods up to 24 months
Main procurement category
Services
CPV classifications
- 85140000 – Miscellaneous health services
- 85145000 – Services provided by medical laboratories
- 85148000 – Medical analysis services
- 71900000 – Laboratory services
Participation
Legal and financial capacity conditions of participation
This procurement is conducted in accordance with the requirements of Article 8 of the
Financing Agreement establishing the PEACEPLUS Programme for 2021-2027, which
requires the procurement procedures under Articles 181 and 182 of Regulation (EU,
Euratom) 2024/2509 to be applied
Submission
Enquiry deadline
11 June 2026, 3:00pm
Tender submission deadline
17 June 2026, 3:00pm
Submission address and any special instructions
Tenders may be submitted electronically
Yes
Languages that may be used for submission
English
Award decision date (estimated)
3 August 2026
Award criteria
| Name | Type | Weighting |
|---|---|---|
| Quallity | Quality | 60% |
| Price | Price | 40% |
Other information
Description of risks to contract performance
This procurement is conducted in accordance with the requirements of Article 8 of the
Financing Agreement establishing the PEACEPLUS Programme for 2021-2027, which
requires the procurement procedures under Articles 181 and 182 of Regulation (EU,
Euratom) 2024/2509 to be applied. Any potential
applicant for review of any decisions taken in connection with the procurement should
seek their own advice in connection with review procedures, but jurisdiction in connection
with such a review is likely to be with the High Court of Justice, by way of a claim for
judicial review or otherwise.
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Justification for not publishing a preliminary market engagement notice
N/A
Contracting authority
ulster university
- Companies House: RC000726
Finance Office
Coleraine
BT521SA
United Kingdom
Region: UKN0C – Causeway Coast and Glens
Organisation type: Public authority – sub-central government
Devolved regulations that apply: Northern Ireland